Inhibition of nucleolin, a pleiotrophin receptor, signaling reversed collagen synthesis in neurofibroma-associated fibroblasts, suggesting that targeting this pathway offers a new therapeutic strategy for plexiform neurofibroma. Here, NUCLEOLIN is linked to plexiform neurofibroma.